-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Reporter | Zheng Jie
Edit | Xie Xin
On April 28th, Gao Demei announced that its injection-filled hyaluronic acid product Relan·Rixuan (hereinafter referred to as "Rixuan") was approved for the first domestic indication for nasal back and/or nose root shaping.
At the same time, the other two A modified sodium hyaluronate gel containing lidocaine for injection is also officially launched
.
The medical beauty market is rising.
In 2019, the scale of China's medical beauty market reached 143.
6 billion yuan.
Among them, hyaluronic acid (sodium hyaluronate) medical beauty products are even more popular.
Share prices of Huaxi Biotech and Amic, whose main business involves hyaluronic acid It has been rising steadily, and Aimeike is driven by the positioning of "Hi-body".
As the only domestic small molecule hyaluronic acid product approved for neck-stroke indications, "Hi-body" will be the only product for Aimeike in 2020.
Contributed 447 million yuan in revenue, a growth rate of 84%, accounting for about 63.
1% of overall revenue
.
From this point of view, Rexuan’s strategy is to first take the relatively blank market for the indications of nasal back and/or nose root shaping, and take the differentiated single product route
.
Lei Hongyu, general manager of Gaodemei China, told Jiemian News that the nose is the first among Asian beauty seekers under the age of 30 for mid-face injection
In 2008, Gaodemei's modified hyaluronic acid gel for injection became the first hyaluronic acid injection approved for marketing in China
.
Today, more than ten years later, the field of hyaluronic acid has become a red sea
Jiemian News reporter found that in the above report, the domestic company ranked first in this field is Amic, and coincidentally, Amic and Gao Demei also formed a competition on the same product, which was originally famous for Faye Wong.
"Tong Yan Zhen"
.
"Children's beauty needle" is a mixture of poly-L-lactic acid and microspheres, which stimulates the growth of own collagen and achieves the purpose of firming the skin
.
Poly-L-lactic acid is an effective substance used to stimulate the skin's own collagen production.
Relatively speaking, hyaluronic acid injections are only cosmetic fillings (short-term recovery after absorption), and the "Tongyan Injection" has a much longer effect.
Therefore, the "Tongyan Injection" is considered to be a major future in the field of medical beauty injections.
Single product
.
While Sculptra, a “children's needle” product under Gao Demei, was approved by the US FDA as early as 2004, but it has not yet entered China.
As for domestic companies, the "Tongyan Needle" of Amec has completed the on-site inspection of the production.